Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-92

don’t ask me that. No one knows but we are not a 9 million market cap

All we know is the fundamentals

- CEO and directors buying more at 7.5 cents one month before potential GLP results then straight into phase 1
- 10 million in funding
- 5-10 million dollar grant on Walter Reed study
- phase 1 is for both stroke and traumatic brain injury ( CEO calls is 2 for one study and saves us millions)
- Peers in this space in the same position as us are 70-100 million dollar market caps

it went up from 2 cents to 15 cents there is too many donkeys in the money and selling below out funding and below the CEO just funny